| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Exicure Inc (NASDAQ: XCUR)
XCUR Technical Analysis
4
| As on 9th Jun 2023 XCUR SHARE Price closed @ 0.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.85 & Strong Buy for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XCURSHARE Price
| Open | 0.93 | Change | Price | % |
| High | 0.99 | 1 Day | 0.01 | 1.06 |
| Low | 0.92 | 1 Week | 0.09 | 10.47 |
| Close | 0.95 | 1 Month | 0.03 | 3.26 |
| Volume | 91266 | 1 Year | 0.71 | 295.83 |
| 52 Week High 2.50 | 52 Week Low 0.09 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XCUR Daily Charts |
XCUR Intraday Charts |
Whats New @ Bazaartrend |
XCUR Free Analysis |
|
|
XCUR Important Levels Intraday
| RESISTANCE | 1.08 |
| RESISTANCE | 1.04 |
| RESISTANCE | 1.01 |
| RESISTANCE | 0.99 |
| SUPPORT | 0.91 |
| SUPPORT | 0.89 |
| SUPPORT | 0.86 |
| SUPPORT | 0.82 |
XCUR Forecast April 2024
| 4th UP Forecast | 1.18 |
| 3rd UP Forecast | 1.11 |
| 2nd UP Forecast | 1.06 |
| 1st UP Forecast | 1.02 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | 0.84 |
| 3rd DOWN Forecast | 0.79 |
| 4th DOWN Forecast | 0.72 |
XCUR Weekly Forecast
| 4th UP Forecast | 1.05 |
| 3rd UP Forecast | 1.02 |
| 2nd UP Forecast | 1.00 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | 0.92 |
| 2nd DOWN Forecast | 0.90 |
| 3rd DOWN Forecast | 0.88 |
| 4th DOWN Forecast | 0.85 |
XCUR Forecast2024
| 4th UP Forecast | 7.04 |
| 3rd UP Forecast | 5.09 |
| 2nd UP Forecast | 3.88 |
| 1st UP Forecast | 2.67 |
| 1st DOWN Forecast | -0.77 |
| 2nd DOWN Forecast | -1.98 |
| 3rd DOWN Forecast | -3.19 |
| 4th DOWN Forecast | -5.14 |
Exicure Inc ( NASDAQ USA Symbol : XCUR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XCUR Business Profile
Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors. The company is also developing XCUR-FXN, an SNA?based therapeutic candidate that is in preclinical trials for the treatment of Friedreich's ataxia; XCUR17, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha; and AST-005, an SNA targeting TNF for the treatment of mild to moderate psoriasis. It has a collaboration, option, and license agreement with Allergan Pharmaceuticals International Limited to develop SNA-based treatments for hair loss disorders; license and development agreement with DERMELIX, LLC to research, develop, and commercialize its technology for the treatment of netherton syndrome; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. The company was founded in 2011 and is headquartered in Chicago, Illinois. Address: 2430 North Halsted Street, Chicago, IL, United States, 60614
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service